• (S)-(+)-Dimethindene maleate: M2 Workflow

  2026-09-04

  This guide explains how to plan and quality-control experiments using (S)-(+)-Dimethindene maleate (SKU B6734) as an M2 muscarinic receptor antagonist with additional histamine H1 antagonist activity. It is intended for scientific research workflows, not clinical, diagnostic, or therapeutic use, and emphasizes salt-aware calculations, prompt solution use, and receptor-selectivity controls.

• DiI (DiIC18(3)) Plasma Membrane Probe

  2026-09-04

  DiI (DiIC18(3)) is a lipophilic orange fluorescent membrane dye for labeling plasma membranes in live or fixed cells and tissues. It is useful for neuronal tracing, migration, adhesion, fusion, and lipoprotein workflows, but it is water-insoluble and should not be treated as a general intracellular organelle stain, particularly after detergent permeabilization.

• Carvedilol Phosphate for GPCR and IRI Studies

  2026-09-03

  Carvedilol Phosphate offers a practical pharmacological perturbation for non-selective beta-adrenergic and alpha-1 receptor signaling in cell-based assays. This guide connects formulation, hypoxia–reoxygenation workflows, macrophage-polarization readouts, and troubleshooting to the Arrb2–6-ketoLCA axis reported in hepatic ischemia–reperfusion research.

• IEM 1460: From AMPA Blockade to Translation

  2026-09-03

  A translational framework for using IEM 1460 as a selective AMPA receptor blocker to dissect excitotoxicity, synaptic transmission modulation, and neuroprotection while distinguishing receptor-selective evidence from broader seizure-model findings.

• Drosophila Keap1 Nuclear Condensates Under Stress

  2026-09-02

  This study identifies stress-responsive nuclear condensate formation as a previously uncharacterized function of Drosophila Keap1, linking its N- and C-terminal regions to the organization of nuclear foci. The findings provide a mechanistic framework for studying how Keap1 proteins may influence chromatin-associated regulation beyond their canonical cytoplasmic control of Nrf2-family factors.

• Nicotine Signaling and CKD Progression in Smokers

  2026-09-02

  Jain and Jaimes synthesize clinical and experimental evidence linking cigarette smoking, nicotine receptor signaling, oxidative stress, and renal fibrosis in chronic kidney disease. The review’s main contribution is its mechanistic focus on non-neuronal nicotinic acetylcholine receptors, particularly α7-nAChR, while also clarifying why nicotine-specific effects must be distinguished from the broader toxicology of cigarette smoke.

• Methoxy-X04 for Mechanism-Driven Aβ Imaging

  2026-09-01

  Methoxy-X04 is a fluorescent amyloid beta probe for connecting plaque imaging with microglial clearance and therapeutic-response studies. This guide explains how to interpret fibril, oligomer, and cerebrovascular signals alongside the rTMS–Cx3cl1–Cx3cr1 findings in Alzheimer’s disease models.

• Inducing Right Ventricular-Like Cardiomyocytes

  2026-09-01

  Saito and colleagues developed a modified human pluripotent stem cell differentiation strategy that shifts cardiac progenitors from a first heart field-like toward an anterior second heart field-like identity, enabling generation of right ventricular-like cardiomyocytes. The resulting cells differed from left ventricular-like controls in gene expression, spontaneous contraction, calcium handling, and cell size, providing a useful platform for chamber-specific disease modeling.

• PP 2 (AG 1879) for Src Signaling Research

  2026-08-31

  PP 2 (AG 1879) provides a practical chemical probe for separating Src-family kinase signaling from downstream calcium and oxidative-stress mechanisms. This workflow-focused guide connects cancer and immune assays with vascular pharmacology, emphasizing controls, solubility, and interpretation limits.

• Dabigatran Etexilate: Oral Direct Thrombin Inhibition

  2026-08-31

  The reference review presents dabigatran etexilate as the first marketed oral direct thrombin inhibitor in the United States, emphasizing its rapid, predictable anticoagulant activity and reduced dependence on routine INR monitoring. Its prodrug activation through carboxylesterases, lack of CYP450 involvement, renal clearance considerations, and clinical evidence across thromboembolic indications define both its practical value and its interaction-study implications.

• ALDH2 Activation Delays Pressure-Overload Heart Failure

  2026-08-30

  The reference study identifies ALDH2 as more than a mitochondrial aldehyde-detoxification enzyme: its activation also preserves cardiomyocyte proliferative capacity and delays pressure overload-induced heart failure in mice. By combining neonatal cardiomyocyte experiments with an adult transverse aortic constriction model, the work connects ALDH2 activity to cardiac regeneration and provides a framework for testing pharmacological activation in cardiac disease research.

• Radicicol: From Hsp90 Inhibition to Translation

  2026-08-29

  A mechanistic and translational framework for using Radicicol across Hsp90, PDK3, adipogenesis, ovarian carcinoma apoptosis, and sepsis inflammation studies—while preserving assay rigor and biological interpretation.

• FITC Goat Anti-Mouse IgG: From Signal to Biology

  2026-08-28

  Learn how the FITC Goat Anti-Mouse IgG (H+L) Antibody converts mouse-primary-antibody binding into interpretable fluorescence, from MAVS pathway studies to assay design. This article connects secondary-antibody chemistry with controls, imaging strategy, and mechanistic confidence.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-08-28

  This study identifies Kupffer cell TMEM16F as a key determinant of host protection during Listeria monocytogenes infection. By combining cell type-specific knockout mice with plasma-membrane repair, inflammation, and liver-metabolism analyses, the authors show that TMEM16F limits Kupffer cell rupture and prevents secondary hepatic injury.

• Guanabenz Acetate: From GPCRs to Immune Signaling

  2026-08-27

  A translational framework for using Guanabenz Acetate to connect α2-adrenergic receptor pharmacology with stress-granule and innate immune research—without confusing a mechanistic hypothesis with an antiviral claim.

7886 records 1/526 page Next 12345 下5页 Last page